Cancer: A Multifaceted Enemy and the Precision Oncology Response-Reference-Cited by-同舟云学术

Cancer: A Multifaceted Enemy and the Precision Oncology Response

Published:2024-05-21 Issue:11 Volume:25 Page:5577
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Levantini Elena¹^ORCID

Affiliation:

1. Institute of Biomedical Technologies, National Research Council (CNR), Area della Ricerca di Pisa, 56124 Pisa, Italy

Abstract

Cancer heterogeneity presents a major obstacle in clinical practice that grants tumor cells remarkable levels of resilience, adaptability, and invasiveness [...]

Funder

AIRC Investigator

Gheraldeschi and Pecoraro families

PNNR THE Spoke 1

Publisher

MDPI AG

Link

https://www.mdpi.com/1422-0067/25/11/5577/pdf

Reference13 articles.

1. Is miR therapeutic targeting still a miRage?;Levantini;Front. Biosci. (Landmark Ed.),2021

2. Camargo-Herrera, V., Castellanos, G., Rangel, N., Jimenez-Tobon, G.A., Martinez-Aguero, M., and Rondon-Lagos, M. (2024). Patterns of Chromosomal Instability and Clonal Heterogeneity in Luminal B Breast Cancer: A Pilot Study. Int. J. Mol. Sci., 25.

3. Lee, J.H., Kim, J., Kim, H.S., and Kang, Y.J. (2023). Unraveling Connective Tissue Growth Factor as a Therapeutic Target and Assessing Kahweol as a Potential Drug Candidate in Triple-Negative Breast Cancer Treatment. Int. J. Mol. Sci., 24.

4. Lee, J., Ha, H.J., Kim, D.Y., Koh, J.S., and Kim, E.J. (2023). Analysis of Under-Diagnosed Malignancy during Fine Needle Aspiration Cytology of Lymphadenopathies. Int. J. Mol. Sci., 24.

5. Bermes, M., Rodriguez, M.J., de Toledo, M.A.S., Ernst, S., Muller-Newen, G., Brummendorf, T.H., Chatain, N., Koschmieder, S., and Baumeister, J. (2023). Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms. Int. J. Mol. Sci., 24.